Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1657 1798 1799
This examiner grants 41% of resolved cases
Nathan Gregory Esperon is an examiner in Tech Center 1700 and Art Unit 1657 with 122 resolved cases. The allowance rate of 41.0 percent suggests a more restrictive examination environment compared to many other examiners in the same tech center. Furthermore, the median days to allowance is 1430, indicating a prolonged prosecution period that requires patience and persistent effort from applicants.
Despite the lower allowance rate, the interview lift of 23.3 percent offers a clear path for improving outcomes. This lift indicates that interviews are a valuable tool for overcoming rejections and reaching an agreement in the 122 resolved cases. Applicants should consider the 1430-day timeline and the 41.0 percent allowance rate when deciding whether to pursue an interview to leverage the 23.3 percent lift. The data suggests that while the baseline is challenging, direct communication can significantly shift the odds in the applicant's favor.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18488117 | CELL DETACHMENT DEVICE AND CELL DETACHMENT METHOD | Non-Final OA | CANON KABUSHIKI KAISHA |
| 17911553 | REAGENT INJECTIONS INTO CELLS | Non-Final OA | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. |
| 17287349 | MULTIPLEXED SINGLE-CELL ANALYSIS USING OPTICALLY-ENCODED RNA CAPTURE PARTICLES | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 17442709 | GREENHOUSE GAS IMPROVED FERMENTATION | Final Rejection | DSM IP ASSETS B.V. |
| 17522726 | GAS BIOCATALYSIS VIA AN IMMOBILIZED CELL BIOREACTOR | Non-Final OA | Alliance for Energy Innovation, LLC |
| 17955738 | CELL SEPARATION PARTICLES FOR AND/NOT OPERATIONS OR MULTIPLE TARGETS | Non-Final OA | The Charles Stark Draper Laboratory, Inc. |
| 17712989 | Additive Manufacturing of a Packed Bed Bioreactor | Non-Final OA | The Government of the United States of America, as represented by the Secretary of the Navy |
| 16379133 | SENSOR RECEPTACLE FOR A BIOREACTOR, AND BIOREACTOR WITH SENSOR RECEPTACLE, AND METHOD FOR PROPAGATION OR CULTIVATION OF BIOLOGICAL MATERIAL | Non-Final OA | SCHOTT AG |
| 18454368 | METHODS AND SYSTEMS FOR PROPAGATING MICROORGANISMS FOR MITIGATING MYCOTOXIN CONTAMINATION, AND RELATED SYSTEMS AND METHODS | Final Rejection | POET Research, Inc. |
| 18020527 | BIOPROCESSING SYSTEM AND APPARATUS FOR REDUCING CELL SHEAR IN A BIOPROCESSING SYSTEM | Final Rejection | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC |
| 18020377 | NUCLEIC ACID AMPLIFICATION CHIP | Final Rejection | KYORIN PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy